-
1
-
-
12944271053
-
Cancer statistics, 2005
-
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005. (Pubitemid 40310185)
-
(2005)
Ca-A Cancer Journal for Clinicians
, vol.55
, Issue.1
, pp. 10-30
-
-
Jemal, A.1
Murray, T.2
Ward, E.3
Samuels, A.4
Tiwari, R.C.5
Ghafoor, A.6
Feuer, E.J.7
Thun, M.J.8
-
2
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
4
-
-
33947315736
-
Cancer epigenomics: DNA methylomes and histone-modification maps
-
Esteller M: Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298, 2007.
-
(2007)
Nat Rev Genet
, vol.8
, pp. 286-298
-
-
Esteller, M.1
-
5
-
-
40849139208
-
Epigenetics in cancer
-
Esteller M: Epigenetics in cancer. New Engl J Med 358: 1148-1159, 2008.
-
(2008)
New Engl J Med
, vol.358
, pp. 1148-1159
-
-
Esteller, M.1
-
6
-
-
78651313568
-
Promoter CpG island hypermethylation during breast cancer progression
-
Park SY, Kwon HJ, Lee HE, et al: Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch 458: 73-84, 2011.
-
(2011)
Virchows Arch
, vol.458
, pp. 73-84
-
-
Park, S.Y.1
Kwon, H.J.2
Lee, H.E.3
-
7
-
-
67651005638
-
Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis
-
Orlando FA and Brown KD: Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis. Ann Surg Oncol 16: 2270-2279, 2009.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 2270-2279
-
-
Orlando, F.A.1
Brown, K.D.2
-
9
-
-
79954526429
-
Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation
-
Candiloro IL, Mikeska T and Dobrovic A: Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics 6: 500-507, 2011.
-
(2011)
Epigenetics
, vol.6
, pp. 500-507
-
-
Candiloro, I.L.1
Mikeska, T.2
Dobrovic, A.3
-
11
-
-
0034028030
-
Repair of O (6)-alkylguanine by alkyltransferases
-
Pegg AE: Repair of O (6)-alkylguanine by alkyltransferases. Mut Res 462: 83-100, 2000.
-
(2000)
Mut Res
, vol.462
, pp. 83-100
-
-
Pegg, A.E.1
-
13
-
-
0032428332
-
Death associated proteins (DAPs): From gene identification to the analysis of their apoptotic and tumor suppressive functions
-
Levy-Strumpf N and Kimchi A: Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 17: 3331-3340, 1998. (Pubitemid 29043985)
-
(1998)
Oncogene
, vol.17
, Issue.25
, pp. 3331-3340
-
-
Levy-Strumpf, N.1
Kimchi, A.2
-
14
-
-
77955713764
-
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death
-
Laborde E: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 17: 1373-1380, 2010.
-
(2010)
Cell Death Differ
, vol.17
, pp. 1373-1380
-
-
Laborde, E.1
-
15
-
-
66149141021
-
PTEN and the PI3-kinase pathway in cancer
-
Chalhoub N and Baker SJ: PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150, 2009.
-
(2009)
Annu Rev Pathol
, vol.4
, pp. 127-150
-
-
Chalhoub, N.1
Baker, S.J.2
-
16
-
-
52649109068
-
The TRAIL apoptotic pathway in cancer onset, progression and therapy
-
Johnstone RW, Frew AJ and Smyth MJ: The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8: 782-798, 2008.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 782-798
-
-
Johnstone, R.W.1
Frew, A.J.2
Smyth, M.J.3
-
18
-
-
17644415807
-
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
-
IARC Press, Lyon
-
Tavassoli FA and Devilee P (eds): Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours. IARC Press, Lyon, 2003.
-
(2003)
WHO Classification of Tumours
-
-
Tavassoli, F.A.1
Devilee, P.2
-
19
-
-
4644297522
-
Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients
-
DOI 10.1158/1078-0432.CCR-04-0597
-
Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T and Cairns P: Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10: 6189-6193, 2004. (Pubitemid 39287525)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.18 I
, pp. 6189-6193
-
-
Dulaimi, E.1
Hillinck, J.2
De Caceres, I.I.3
Al-Saleem, T.4
Cairns, P.5
-
20
-
-
63449113187
-
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
-
Review
-
Dworkin AM, Huang TH and Toland AE: Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment (Review). Semin Cancer Biol 19: 165-171, 2009.
-
(2009)
Semin Cancer Biol
, vol.19
, pp. 165-171
-
-
Dworkin, A.M.1
Huang, T.H.2
Toland, A.E.3
-
21
-
-
34247849498
-
Methylation-sensitive high resolution melting (MS-HRM): A new approach for sensitive and high-throughput assessment of methylation
-
Wojdacz TK and Dobrovic A: Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 35: e41, 2007.
-
(2007)
Nucleic Acids Res
, vol.35
-
-
Wojdacz, T.K.1
Dobrovic, A.2
-
22
-
-
61449505232
-
Melting curve assays for DNA methylation analysis
-
Wojdacz TK and Dobrovic A: Melting curve assays for DNA methylation analysis. Methods Mol Biol 507: 229-240, 2009.
-
(2009)
Methods Mol Biol
, vol.507
, pp. 229-240
-
-
Wojdacz, T.K.1
Dobrovic, A.2
-
23
-
-
0038678777
-
Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites
-
Colella S, Shen L, Baggerly KA, Issa JP and Krahe R: Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150, 2003. (Pubitemid 36828724)
-
(2003)
BioTechniques
, vol.35
, Issue.1
, pp. 146-150
-
-
Colella, S.1
Shen, L.2
Baggerly, K.A.3
Issa, J.-P.J.4
Krahe, R.5
-
24
-
-
0038476350
-
Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis
-
Kang GH, Lee S, Kim JS and Jung HY: Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 83: 635-641, 2003. (Pubitemid 36618042)
-
(2003)
Laboratory Investigation
, vol.83
, Issue.5
, pp. 635-641
-
-
Kang, G.H.1
Lee, S.2
Kim, J.-S.3
Jung, H.-Y.4
-
25
-
-
0035870248
-
A gene hypermethylation profile of human cancer
-
Esteller M, Corn PG, Baylin SB and Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001. (Pubitemid 32695003)
-
(2001)
Cancer Research
, vol.61
, Issue.8
, pp. 3225-3229
-
-
Esteller, M.1
Corn, P.G.2
Baylin, S.B.3
Herman, J.G.4
-
26
-
-
12144286953
-
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types
-
DOI 10.1002/ijc.20041
-
Shivapurkar N, Toyooka S, Toyooka KO, et al: Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 109: 786-792, 2004. (Pubitemid 38405630)
-
(2004)
International Journal of Cancer
, vol.109
, Issue.5
, pp. 786-792
-
-
Shivapurkar, N.1
Toyooka, S.2
Toyooka, K.O.3
Toyooka, K.O.4
Reddy, J.5
Miyajima, K.6
Suzuki, M.7
Shigematsu, H.8
Takahashi, T.9
Parikh, G.10
Pass, H.I.11
Chaudhary, P.M.12
Gazdar, A.F.13
-
27
-
-
11444266289
-
Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk
-
Lewis CM, Cler LR, Bu D, et al: Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11: 166-172, 2005. (Pubitemid 40081117)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.1
, pp. 166-172
-
-
Lewis, C.M.1
Cler, L.R.2
Bu, D.-W.3
Zochbauer-Muller, S.4
Milchgrub, S.5
Naftalis, E.Z.6
Leitch, A.M.7
Minna, J.D.8
Euhus, D.M.9
-
28
-
-
70350105624
-
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression
-
Hoque MO, Prencipe M, Poeta ML, et al: Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 18: 2694-2700, 2009.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 2694-2700
-
-
Hoque, M.O.1
Prencipe, M.2
Poeta, M.L.3
-
29
-
-
77955787215
-
Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients
-
Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, Dalay N and Santella RM: Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 30: 2489-2496, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 2489-2496
-
-
Cho, Y.H.1
Yazici, H.2
Wu, H.C.3
Terry, M.B.4
Gonzalez, K.5
Qu, M.6
Dalay, N.7
Santella, R.M.8
-
30
-
-
0037112447
-
Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype
-
Lehmann U, Celikkaya G, Hasemeier B, Länger F and Kreipe H: Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 62: 6634-6638, 2002. (Pubitemid 35364131)
-
(2002)
Cancer Research
, vol.62
, Issue.22
, pp. 6634-6638
-
-
Lehmann, U.1
Celikkaya, G.2
Hasemeier, B.3
Langer, F.4
Kreipe, H.5
-
31
-
-
0035932393
-
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
-
DOI 10.1038/sj.onc.1204175
-
Agathanggelou A, Honorio S, Macartney DP, et al: Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20: 1509-1518, 2001. (Pubitemid 32291201)
-
(2001)
Oncogene
, vol.20
, Issue.12
, pp. 1509-1518
-
-
Agathanggelou, A.1
Honorio, S.2
Macartney, D.P.3
Martinez, A.4
Dallol, A.5
Rader, J.6
Fullwood, P.7
Chauhan, A.8
Walker, R.9
Shaw, J.A.10
Hosoe, S.11
Lerman, M.I.12
Minna, J.D.13
Maher, E.R.14
Latif, F.15
-
32
-
-
0035795676
-
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
-
Burbee DG, Forgacs E, Zöchbauer-Müller S, et al: Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699, 2001. (Pubitemid 32492810)
-
(2001)
Journal of the National Cancer Institute
, vol.93
, Issue.9
, pp. 691-699
-
-
Burbee, D.G.1
Forgacs, E.2
Zochbauer-Muller, S.3
Shivakumar, L.4
Fong, K.5
Gao, B.6
Randle, D.7
Kondo, M.8
Virmani, A.9
Bader, S.10
Sekido, Y.11
Latif, F.12
Milchgrub, S.13
Toyooka, S.14
Gazdar, A.F.15
Lerman, M.I.16
Zabarovsky, E.17
White, M.18
Minna, J.D.19
-
33
-
-
67349087533
-
Prognostic significance of RASSF1A promoter methylation in operable breast cancer
-
Kioulafa M, Kaklamanis L, Mavroudis D, Georgoulias V and Lianidou ES: Prognostic significance of RASSF1A promoter methylation in operable breast cancer. Clin Biochem 42: 970-975, 2009.
-
(2009)
Clin Biochem
, vol.42
, pp. 970-975
-
-
Kioulafa, M.1
Kaklamanis, L.2
Mavroudis, D.3
Georgoulias, V.4
Lianidou, E.S.5
-
34
-
-
77954086798
-
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
-
Muggerud AA, Rønneberg JA, Wärnberg F, et al: Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res 12: R3, 2010.
-
(2010)
Breast Cancer Res
, vol.12
-
-
Muggerud, A.A.1
Rønneberg, J.A.2
Wärnberg, F.3
-
35
-
-
74049117092
-
Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients
-
Karray-Chouayekh S, Trifa F, Khabir A, et al: Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients. J Cancer Res Clin Oncol 136: 203-210, 2010.
-
(2010)
J Cancer Res Clin Oncol
, vol.136
, pp. 203-210
-
-
Karray-Chouayekh, S.1
Trifa, F.2
Khabir, A.3
-
36
-
-
77954247556
-
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
-
Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P and Ralhan R: Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci 87: 83-91, 2010.
-
(2010)
Life Sci
, vol.87
, pp. 83-91
-
-
Sharma, G.1
Mirza, S.2
Parshad, R.3
Srivastava, A.4
Gupta, S.D.5
Pandya, P.6
Ralhan, R.7
-
38
-
-
34250897975
-
GSTP1 promoter hypermethylation is an early event in breast carcinogenesis
-
Lee JS: GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch 450: 637-642, 2007.
-
(2007)
Virchows Arch
, vol.450
, pp. 637-642
-
-
Lee, J.S.1
-
39
-
-
63349105568
-
Methylation profiles in breast cancer
-
Buyru N, Altinisik J, Ozdemir F, Demokan S and Dalay N: Methylation profiles in breast cancer. Cancer Invest 27: 307-312, 2009.
-
(2009)
Cancer Invest
, vol.27
, pp. 307-312
-
-
Buyru, N.1
Altinisik, J.2
Ozdemir, F.3
Demokan, S.4
Dalay, N.5
-
40
-
-
33750364352
-
Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers
-
DOI 10.1007/s10549-006-9241-9
-
Arai T, Miyoshi Y, Kim SJ, Taguchi T, Tamaki Y and Noguchi S: Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 100: 169-176, 2006. (Pubitemid 44631918)
-
(2006)
Breast Cancer Research and Treatment
, vol.100
, Issue.2
, pp. 169-176
-
-
Arai, T.1
Miyoshi, Y.2
Kim, S.J.3
Taguchi, T.4
Tamaki, Y.5
Noguchi, S.6
-
41
-
-
71949122380
-
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients
-
Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S and Ralhan R: Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol 31: 487-500, 2009.
-
(2009)
Cell Oncol
, vol.31
, pp. 487-500
-
-
Sharma, G.1
Mirza, S.2
Yang, Y.H.3
Parshad, R.4
Hazrah, P.5
Datta Gupta, S.6
Ralhan, R.7
|